edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics
Stock NewsThemesEli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics

Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics

Edgen StockEdgen Stock·Sep 08 2025, 08:09
Share to
Share to
Copy link
LLYLLY+1.43%NVONVO+1.00%GDRXGDRX+1.09%
Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics
source:
[1] Why weight-loss 'wonder drugs' aren't 'wonder stocks' — yet (https://finance.yahoo.com/news/why-weight-los ...)[2] Eli Lilly eyes orforglipron approval after Phase III diabetes trial success (https://vertexaisearch.cloud.google.com/groun ...)[3] Why obesity stocks are struggling in 2025? - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)

Related News

Babcock & Wilcox Secures $40M Refinery Contract
Dec 19 2025, 22:38

Babcock & Wilcox Secures $40M Refinery Contract

Babcock & Wilcox announced on December 19, 2025, that it secured a $40 million contract to supply its Wet Gas Scrubbing technology to a Canadian petroleum refinery, major Canadian petroleum refinery.

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales
Dec 19 2025, 22:29

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

A Yale study finds Elon Musk's political stance cost Tesla 1.26 million car sales, contributing to a profit drop to $7.1 billion in 2024 from $15 billion in 2023.

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes
Dec 19 2025, 22:27

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes

On December 16, Mizuho increased its price target for Tesla to $530, citing growing confidence in the automaker's future robotaxi business.